Suchergebnisse - "Vermeire, S"

PubPharm (274)

21

Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis : a Real-World Belgian Cohort Study

enthalten in: Inflammatory bowel diseases | 2018

von Van de Vondel, S. | Baert, F. | Reenaers, C. | +40

22

Physicians' perspective on the clinical meaningfulness of inflammatory bowel disease trial results : an International Organization for the Study of Inflammatory Bowel Disease (IOIBD) survey

enthalten in: Alimentary pharmacology & therapeutics | 2018

von Olivera, P. | Sandborn, W. | Panés, J. | +5

CommentIn: Aliment Pharmacol Ther. 2018 Apr;47(7):1032-1033. - PMID 29512917

23

Outcome of restorative proctocolectomy with an ileo-anal pouch for ulcerative colitis : effect of changes in clinical practice

enthalten in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland | 2018

von Germain, A. | de Buck van Overstraeten, A. | Wolthuis, A. | +4

24

Exposure-response relationship of certolizumab pegol induction and maintenance therapy in patients with Crohn's disease

enthalten in: Alimentary pharmacology & therapeutics | 2018

von Vande Casteele, N. | Feagan, B. | Vermeire, S. | +4

25

Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD)

enthalten in: Acta gastro-enterologica Belgica | 2018

von Franchimont, D. | Ferrante, M. | Louis, E. | +9

26

Anti‐infliximab antibody concentrations can guide treatment intensification in patients with Crohn's disease who lose clinical response

enthalten in: Alimentary Pharmacology & Therapeutics | 2018

von Dreesen, E. | Van Stappen, T. | Ballet, V. | +8

27

Physicians’ perspective on the clinical meaningfulness of inflammatory bowel disease trial results : an International Organization for the Study of Inflammatory Bowel Disease ( IOIBD) survey

enthalten in: Alimentary Pharmacology & Therapeutics | 2018

von Olivera, P. | Sandborn, W. | Panés, J. | +5

28

Anti-infliximab antibody concentrations can guide treatment intensification in patients with Crohn's disease who lose clinical response

enthalten in: Alimentary pharmacology & therapeutics | 2018

von Dreesen, E. | Van Stappen, T. | Ballet, V. | +8

CommentIn: Aliment Pharmacol Ther. 2018 Mar;47(6):845-846. - PMID 29446128

29

Short- and medium-term outcomes following primary ileocaecal resection for Crohn's disease in two specialist centres

enthalten in: The British journal of surgery | 2017

von de Buck van Overstraeten, A. | Eshuis, E. | Vermeire, S. | +9

30

Editorial : vedolizumab in pregnancy - is gut selectivity as good for baby as it is for mum? Authors' reply

enthalten in: Alimentary pharmacology & therapeutics | 2017

von Mahadevan, U. | Vermeire, S. | Lasch, K. | +4

CommentOn: Aliment Pharmacol Ther. 2017 Apr;45(7):941-950. - PMID 28169436